According to Harvard Bioscience's latest financial reports the company's total assets are $0.12 Billion USD. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2024-12-31 | $0.12 B | -7.81% |
2023-12-31 | $0.13 B | -5.5% |
2022-12-31 | $0.14 B | -10.46% |
2021-12-31 | $0.16 B | 3.9% |
2020-12-31 | $0.15 B | -5.23% |
2019-12-31 | $0.16 B | -2.22% |
2018-12-31 | $0.16 B | 54.19% |
2017-12-31 | $0.10 B | 1.47% |
2016-12-31 | $0.10 B | -10.23% |
2015-12-31 | $0.12 B | -11.67% |
2014-12-31 | $0.13 B | 0.34% |
2013-12-31 | $0.13 B | 1.48% |
2012-12-31 | $0.13 B | 5.41% |
2011-12-31 | $0.12 B | 1.47% |
2010-12-31 | $0.12 B | 16.38% |
2009-12-31 | $0.10 B | 31.94% |
2008-12-31 | $81.27 M | -17.79% |
2007-12-31 | $98.85 M | 6.03% |
2006-12-31 | $93.22 M | 1.74% |
2005-12-31 | $91.63 M | -34.49% |
2004-12-31 | $0.13 B | 8.92% |
2003-12-31 | $0.12 B | 19.38% |
2002-12-31 | $0.10 B | 30.62% |
2001-12-31 | $82.36 M |